Home
Company Profile
Technology and Approach
Targeted Diseases
Company News
Clinical Outcomes Improvement
Clinical Trials
Questions & Answers
Email Alerts
Contact Us
GenoMed, Inc.
3700 Island Blvd
Aventura, FL 33160
USA
305-705-9922
Publications
From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an Example
Is Angiotensin I-Converting Enzyme a "Master" Disease Gene?
Is "Somatic" Angiotensin I-Converting Enzyme a Mechanosensor?
Pathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes
Why AT1R blockade makes sense for SARS
The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Written evidence included in July 7, 2009 report on genomic medicine by the British House of Lords (
view report
)
Are Blockbuster Drugs Still Possible in the Era of Personalized Medicine?
A Modern-Day Tuskegee... and What's Really Wrong with U.S. Health Care Today?
© 2001-2012 GenoMed. All rights reserved.
Powered by
InvoDesign